UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032250
Receipt number R000036776
Scientific Title Dual center study of usefulness of probe-based confocal laser endomicroscopy for suspected ulcerative colitis-associated neoplasia
Date of disclosure of the study information 2018/04/14
Last modified on 2023/10/08 22:33:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Dual center study of usefulness of probe-based confocal laser endomicroscopy for suspected ulcerative colitis-associated neoplasia

Acronym

Dual center study of pCLE for UCAN

Scientific Title

Dual center study of usefulness of probe-based confocal laser endomicroscopy for suspected ulcerative colitis-associated neoplasia

Scientific Title:Acronym

Dual center study of pCLE for UCAN

Region

Japan


Condition

Condition

suspected ulcerative colitis-associated neoplasia

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We previously published the usefulness of probe-based confocal laser endomicroscopy (pCLE) for the diangosis of ulcerative colitis-associated neoplasia(UCAN)(Dig Endosc. 2017 Jul;29(5):626-633).Here, we prospectively validate the findings of pCLE for the diagnosis of UCAN in the dual center study (Fujita Health University Hospital and Keio University Hospital).

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Diagnostic yields of pCLE, magnifying narrow band imaging (NBI), and magnifying choromoendoscopy for suspected UCAN, compared with pathological diagnosis.

Key secondary outcomes

Adverse events of pCLE and fluorescein


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Medicine

Interventions/Control_1

pCLE after intravenous administration of fluorescein

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

Suspected UCAN

Key exclusion criteria

1. Patients with prevous history of allergy to fluorescein
2. Patients in too bad condition to undergo endoscopy.
3. Patients with severe diabetes
4. Patients with severe cardiac disease
5. Patients with severe cerebrovascular disease
6. Patients with cirrhosis
7. Patients with pheochomocytoma
8. Patients with bleeding tendencies
9. Pregnant or possible pregnant women
10. Patients with contraindication of endoscopy

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Naoki Ohmiya

Organization

Fujita Health University School of Medicine

Division name

Department of Gastroenterology

Zip code


Address

1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, Japan

TEL

0562-93-9240

Email

nohmiya@fujita-hu.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Naoki Ohmiya

Organization

Fujita Health University School of Medicine

Division name

Department of Gastroenterology

Zip code


Address

1-98 Dengakugakubo Kutsukake-cho, Toyoake, Aichi

TEL

0562-93-9240

Homepage URL


Email

nohmiya@fujita-hu.ac.jp


Sponsor or person

Institute

Fujita Health University School of Medicine, Department of Gastroenterology

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Center for Diagnostic and Therapeutic Endoscopy, School of Medicine Keio
University

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

藤田保健衛生大学病院(愛知県)、慶應義塾大学病院(東京都)


Other administrative information

Date of disclosure of the study information

2018 Year 04 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

Enrolled and validated from now

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2017 Year 12 Month 14 Day

Date of IRB

2017 Year 12 Month 14 Day

Anticipated trial start date

2017 Year 12 Month 15 Day

Last follow-up date

2021 Year 12 Month 31 Day

Date of closure to data entry

2022 Year 03 Month 31 Day

Date trial data considered complete

2022 Year 05 Month 31 Day

Date analysis concluded

2023 Year 06 Month 30 Day


Other

Other related information



Management information

Registered date

2018 Year 04 Month 14 Day

Last modified on

2023 Year 10 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036776


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name